HeartBeam Inc BEAT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
HeartBeam Reports Third Quarter 2026 Results
HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time
HeartBeam Announces Positive Heart Attack Pilot Study Results at TCT 2026: Patient-Recorded 3D ECG Shown to Be as Accurate as Standard 12-Lead ECG
HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
Trading Information
- Previous Close Price
- $0.40
- Day Range
- $0.37–0.40
- 52-Week Range
- $0.36–3.98
- Bid/Ask
- $0.39 / $0.40
- Shares Outstanding
- 63.31M
- Market Cap
- $21.92M
- Volume/Avg
- 701,054 / 7M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 16
- Website
- https://www.heartbeam.com
Valuation
Metric | BEAT |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.56 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | BEAT |
|---|---|
Quick Ratio | 4.47 |
Current Ratio | 4.64 |
Interest Coverage | — |
Quick Ratio
BEAT
Profitability
Metric | BEAT |
|---|---|
Return on Assets (Normalized) | −204.91% |
Return on Equity (Normalized) | −348.21% |
Return on Invested Capital (Normalized) | −352.03% |
Return on Assets
BEAT
Health Information Services Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A VEEV | LOCK|RDBYf?kq | LOCK|?@ | $49B | |||
| Pro Medicus Ltd PMCUF | — | LOCK|rJ!! | $14B | |||
| Pro Medicus Ltd ADR PMDIY | — | LOCK|#?J?! | $14B | |||
| BrightSpring Health Services Inc BTSG | — | LOCK|Dxrtv | $14B | |||
| Tempus AI Inc Class A common stock TEM | — | LOCK|sn | $14B | |||
| Hinge Health Inc Ordinary Shares - Class A HNGE | — | LOCK|j><^z | $10B | |||
| HealthEquity Inc HQY | — | LOCK|?zj!% | $9B | |||
| M3 Inc MTHRF | — | LOCK|J<Ml! | $8B | |||
| M3 Inc ADR MTHRY | — | LOCK|D@B@ | $8B | |||
| Doximity Inc Class A DOCS | — | LOCK|###nJ | $6B |
United States